MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT

Device Roche Molecular Systems, Inc.
Total Payments
$655,915
Transactions
180
Doctors
56
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2020 $61,556 7 4
2019 $217,860 63 34
2018 $67,112 16 8
2017 $309,386 94 23

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $462,778 25 70.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $127,999 36 19.5%
Travel and Lodging $34,405 61 5.2%
Royalty or License $18,509 2 2.8%
Unspecified $9,793 10 1.5%
Food and Beverage $2,430 46 0.4%

Payments by Type

General
$646,122
170 transactions
Research
$9,793
10 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
RD002705 ROCHE MOLECULAR SYSTEMS, INC. $5,761 0
RD002704 ROCHE MOLECULAR SYSTEMS, INC. $2,638 0
RD002703 ROCHE MOLECULAR SYSTEMS, INC. $1,394 0

Top Doctors Receiving Payments for MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT — Page 3

Doctor Specialty Location Total Records
, MD Internal Medicine Hayward, CA $37.18 1
, MD Pediatrics Columbus, OH $33.68 1
, M.D Cytopathology Rochester, MN $29.00 1
, MD Anatomic Pathology & Clinical Pathology Los Angeles, CA $21.43 1
, MD Internal Medicine New Haven, CT $12.21 1
, MD Pediatric Infectious Diseases Stanford, CA $8.48 1
, M.D Pediatrics Oakland, CA $7.09 1

About MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT

MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT is a device associated with $655,915 in payments to 56 healthcare providers, recorded across 180 transactions in the CMS Open Payments database. The primary manufacturer is Roche Molecular Systems, Inc..

Payment data is available from 2017 to 2020. In 2020, $61,556 was paid across 7 transactions to 4 doctors.

The most common payment nature for MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT is "Consulting Fee" ($462,778, 70.6% of total).

MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT is associated with 3 research studies, including "RD002705" ($5,761).